BROOKSNSEBrooks Laboratories Limited· PharmaceuticalsMediumNeutral
Announced Wed, 8 Apr · 11:46 IST

Atul Ranchal has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Ownership Changes View source PDF

BROOKS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.5%1-day move
₹72.99
prior close
₹71.99
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4+0.0-0.2-0.5-1.5-1.4-2.0-3.2-4.8-10.9-23.1-31.6-8.2-2.8
Up moveDown movePending
AI summary

Atul Ranchal, a promoter of Brooks Laboratories Limited, has submitted a disclosure under SEBI's substantial acquisition regulations for FY 2025-26. The disclosure covers encumbrances on promoter shares, referring to pledges or other charges on shares held by the promoter group. The filing appears to be a routine periodic compliance submission indicating that there are encumbrances on promoter shares, though the specific percentage or number of shares pledged is not detailed in this cover letter. The disclosure was sent to both BSE and NSE.

Likely market impact

This is a standard regulatory filing and does not signal any immediate change in ownership or share price. However, any undisclosed or newly created encumbrances on promoter shares could indicate promoter borrowing against shares, which investors monitor for potential dilution risk.